BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 9437561)

  • 81. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Subdermal contraceptive implants in nurse-midwifery practice.
    Emerling JM; Paluzzi P; Leiva J; Cullins VE
    J Nurse Midwifery; 1993; 38(2 Suppl):80S-87S. PubMed ID: 8483013
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A preliminary report of Norplant implant insertions in a large urban family planning program.
    Crosby UD; Schwarz BE; Gluck KL; Heartwell SF
    Contraception; 1993 Oct; 48(4):359-66. PubMed ID: 8222663
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Contraceptive implant use among inner city teens.
    Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
    J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system.
    Seeber B; Ziehr SC; Gschlieβer A; Moser C; Mattle V; Seger C; Griesmacher A; Concin N; Concin H; Wildt L
    Contraception; 2012 Oct; 86(4):345-9. PubMed ID: 22402256
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of Norplant implants on the pituitary-adrenal axis function and reserve capacity.
    Toppozada MK; Ramadan M; el-Sawi M; Mehanna MT; Khamis Y; Marzouk S
    Contraception; 1997 Jan; 55(1):7-10. PubMed ID: 9013054
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant.
    Wonodirekso S; Au CL; Hadisaputra W; Affandi B; Rogers PA
    Contraception; 1993 Nov; 48(5):481-93. PubMed ID: 7506133
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Another view on Norplant: match method with users.
    Herndon N
    Netw Res Triangle Park N C; 1992 Oct; 13(2):24-6. PubMed ID: 12286081
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Education and counseling for Norplant users.
    Hinkle LT
    J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A comparison of the effects of NORPLANT capsules and NORPLANT-2 rods on clinical chemistry: metabolic changes.
    Singh K; Viegas OA; Ratnam SS
    Ann Acad Med Singap; 1990 Nov; 19(6):833-6. PubMed ID: 2130749
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
    Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
    Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Adolescents and Norplant: preliminary findings of side effects.
    Kozlowski KJ; Rickert VI; Hendon A; Davis P
    J Adolesc Health; 1995 May; 16(5):373-8. PubMed ID: 7662687
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Emory method: a modified approach to Norplant implants removal.
    Sarma SP; Hatcher R
    Contraception; 1994 Jun; 49(6):551-6. PubMed ID: 8070259
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
    Shaaban MM; Salem HT; Abdullah KA
    Contraception; 1985 Dec; 32(6):623-35. PubMed ID: 3937665
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Contraception with progestogens and progesterone during lactation.
    Shaaban MM
    J Steroid Biochem Mol Biol; 1991; 40(4-6):705-10. PubMed ID: 1835650
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
    Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
    [TBL] [Abstract][Full Text] [Related]  

  • 99. New contraceptives in the 1990s.
    O'Connell BJ
    Curr Opin Pediatr; 1995 Aug; 7(4):371-5. PubMed ID: 7581638
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Levonorgestrel subdermal implants (Norplant) for long-term contraception.
    Sharts-Engel NC
    MCN Am J Matern Child Nurs; 1991; 16(4):232. PubMed ID: 1943533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.